NEW YORK, NY / ACCESSWIRE / April 6, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Clover Health Investments, Corp. (NASDAQ:CLOV)
Class Period: October 6, 2020 - February 3, 2021
Lead Plaintiff Deadline: April 6, 2021
According to the complaint, Clover Health Investments, Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover's sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover's
subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover's software was in fact rudimentary; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in CLOV: http://www.kleinstocklaw.com/pslra-1/clover-health-investments-corp-loss-submission-form?id=14400&from=1
fuboTV Inc. (NYSE:FUBO)
Class Period: March 23, 2020 - January 4, 2021
Lead Plaintiff Deadline: April 19, 2021
During the class period, fuboTV Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (ii) Fubo offering of products was subject to undisclosed cost escalations; (iii) Fubo could not successfully compete and perform as sports book operator and could not capitalize on its only sports wagering opportunity; (iv) Fubo's data and inventory was not differentiated to allow Fubo to achieve long-term advertising growth goals and forecasts; (v) Fubo's valuation was overstated in light of its total revenue and subscription levels; (vi) the acquisition of Balto Sport did not provide the stated synergies, internal expertise, and did not expand the Company's addressable market into online sports wagering; and as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Learn about your recoverable losses in FUBO: http://www.kleinstocklaw.com/pslra-1/fubotv-inc-loss-submission-form?id=14400&from=1
Athenex, Inc. (NASDAQ:ATNX)
Class Period: August 7, 2019 - February 26, 2021
Lead Plaintiff Deadline: May 3, 2021
The ATNX lawsuit alleges Athenex, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in ATNX: http://www.kleinstocklaw.com/pslra-1/athenex-inc-loss-submission-form?id=14400&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm